Biotechnology News

Presented positive Phase 2 results for silevertinib in frontline patients with non-classical EGFRm NSCLC at the 2026 ASCO Annual Meeting, including that no patients developed de novo brain metastases...

EDIT-401 on track for CTN submission this month with data update in Q1 2027 Recently presented pre-clinical data demonstrating ~90% or greater mean reduction in multiple atherogenic lipoproteins,...

Nephros Schedules Second Quarter 2026 Financial Results Conference Call

Arcutis today reported financial results for the quarter ended June 30, 2026, and provided a business update.

SUNNYVALE, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...

Io Therapeutics, Inc., announces research demonstrating its experimental drug for Parkinson's disease degrades and reduces alpha-synuclein in neural cells.

Déclaration d'actions et de droits de vote - 31 juillet 2026

VALNEVA Déclaration d’actions et de droits de vote Statut au 31 juillet 2026__________________________________________________________________________________________ Dénomination sociale :...

New 23andMe study of 114,000+ people links CYP2C19 gene variants to SSRI side effects like sexual dysfunction and poor sleep.

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the upcoming availability of SPRQ-Nx...